2-Hydroxybenzylamine

2-Hydroxybenzylamine · MTI Biotech Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2-Hydroxybenzylamine, covering 2025-05-08 to 2025-05-08. Get the full timeline:

Most recent: Clinical Trial Update: 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients [Phase 1, Phase 2]